ANI Pharmaceuticals, Inc. (ANIP)

ANI Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	144.98	221.12	48.23	100.3	7.86	62.33
Cash & Short-Term Investments	153.28	221.12	48.23	100.3	7.86	62.33
Cash Growth	-20.61%	358.49%	-51.92%	1175.43%	-87.38%	44.93%
Receivables	196.36	162.08	165.44	128.53	95.79	72.13
Inventory	148.04	111.2	105.36	81.69	60.8	48.16
Prepaid Expenses	17.28	17.2	8.39	7.59	5.86	4
Restricted Cash	0.04	-	5.01	-	-	-
Other Current Assets	6.3	8.22	11.85	3.67	-	1.08
Total Current Assets	521.3	519.82	344.26	321.78	170.32	187.7
Property, Plant & Equipment	56.7	44.59	43.25	52.67	41.27	40.55
Long-Term Investments	3.6	6.2	8.8	-	-	-
Goodwill	60.43	28.22	28.22	27.89	3.58	3.58
Other Intangible Assets	569.83	209.01	251.64	294.12	188.51	180.39
Long-Term Deferred Tax Assets	67.66	90.71	81.36	67.94	51.7	38.33
Long-Term Deferred Charges	1.1	0.4	-	-	-	-
Other Long-Term Assets	6.76	5.47	2.56	7.21	5.81	6.25
Total Assets	1,287	904.42	760.09	771.6	461.19	456.79
Accounts Payable	60.89	36.68	29.31	22.97	11.26	14.61
Accrued Expenses	83.54	56.28	35.89	27.89	22.92	20.08
Current Portion of Long-Term Debt	7.15	0.85	0.85	0.85	13.24	9.94
Current Portion of Leases	-	1.56	-	-	-	-
Current Income Taxes Payable	-	8.16	-	-	3.91	-
Current Unearned Revenue	-	-	-	-	0.08	0.45
Other Current Liabilities	38.35	41.94	33.4	35.83	27.16	16.6
Total Current Liabilities	189.93	145.48	99.44	87.54	78.57	61.68
Long-Term Debt	618.21	284.82	285.67	286.52	186.55	182.02
Long-Term Leases	6.94	4.11	1.38	-	-	-
Other Long-Term Liabilities	41.49	12.42	35.06	38.8	0.37	0.3
Total Liabilities	856.58	446.82	421.55	412.86	265.49	244
Common Stock	0	0	0	0	0	0
Additional Paid-In Capital	510.9	514.1	403.9	387.84	214.35	200.8
Retained Earnings	-89.6	-80.13	-97.29	-47.77	-4.97	17.58
Treasury Stock	-20.72	-10.08	-5.09	-3.14	-2.25	-0.72
Comprehensive Income & Other	5.37	8.86	12.17	-3.06	-11.44	-4.87
Total Common Equity	405.95	432.75	313.69	333.89	195.7	212.79
Shareholders' Equity	430.8	457.6	338.54	358.74	195.7	212.79
Total Liabilities & Equity	1,287	904.42	760.09	771.6	461.19	456.79
Total Debt	632.31	291.34	287.9	287.37	199.8	191.96
Net Cash (Debt)	-479.03	-70.22	-239.67	-187.07	-191.93	-129.63
Net Cash Per Share	-24.94	-3.86	-14.74	-14.85	-16.04	-10.77
Filing Date Shares Outstanding	19.52	19.72	16.35	16.55	12	11.9
Total Common Shares Outstanding	19.58	19.12	16.35	16.12	12	11.9
Working Capital	331.36	374.34	244.82	234.24	91.76	126.02
Book Value Per Share	20.74	22.64	19.18	20.71	16.31	17.89
Tangible Book Value	-224.3	195.52	33.83	11.88	3.61	28.82
Tangible Book Value Per Share	-11.46	10.23	2.07	0.74	0.30	2.42
Land	-	1.55	1.55	5.95	4.67	4.57
Buildings	-	17.88	16.66	19.97	11.63	10.28
Machinery	-	50.41	53.15	46.77	39.11	34.98
Construction In Progress	-	7.69	4.6	2.94	3.39	3.5

Source: S&P Capital IQ. Standard template. Financial Sources.